Swarajya Logo

WEEKEND SALE: Subscribe For Just ₹̶2̶9̶9̶9̶ ₹699

Claim Now

Insta

Bharat Biotech Says WHO's Emergency Use Licence To Covaxin Will Accelerate Equitable Access Of Vaccine

PTINov 03, 2021, 08:45 PM | Updated 08:45 PM IST

Bharat Biotech's Covaxin
















Bharat Biotech's Covaxin and AstraZeneca-Oxford University's Covishield, manufactured by Serum Institute of India, are the two widely-used COVID-19 vaccines in India.


Join our WhatsApp channel - no spam, only sharp analysis